Should Routine Anticoagulation be the Standard Approach for Patients with COVID-19

/
program_725_poster.jpg

As the utilization of direct oral anticoagulants (DOACs) increases, there is a parallel increase in major bleeding events, especially intracranial hemorrhages, requiring hospitalization. Clinicians are not recognizing or distinguishing major from minor bleeding, or appropriately employing emergent options to manage major bleeding. Recent solutions for DOAC related life-threatening bleeding are under-recognized and under-utilized solutions for patients with these life-threatening emergencies. Over the last 12-18 months, nationally recognized guidelines have provided clear direction on how best to manage these types of major bleeding events. As data emerges regarding new approaches to therapy, clinicians need to be aware of these new and effective approaches and to assess the benefits and risks associated with each of these approaches. Education provided by experts from the EMCREG-International network within this program correctly and promptly address patient treatment approaches to the appropriate healthcare professionals.

This program has a particular focus on patients with COVID-19, and how to approach anticoagulation with them. Hear from leading emergency medicine experts on their perspectives of how to manage these unique situations.

Learning objectives:

  1. Recognize risk factors associated with DOAC-related bleeding and how to manage in a COVID-19 environment

  2. Evaluate thrombotic condition challenges during COVID-19 and the recommendations for the appropriate use of reversal agents

  3. Demonstrate learning on how to apply thromboprophylaxis and the use of reversal agents in an emergent settings

W. Brian Gibler, MD FACEP, FACC, FAHA
President, EMCREG-International
Professor of Emergency Medicine
Director of Business Development
Department of Emergency Medicine
University of Cincinnati College of Medicine
Cincinnati, OH

Rhonda Cadena, MD
Interim Chief, Division of Neurocritical Care
Director, Neurocritical Care Fellowship
Associate Professor
Departments of Neurology, Neurosurgery, and Emergency Medicine
UNC Hospitals
Chapel Hill, NC

William A. Knight IV, MD, FACEP, FNCS
Professor of Emergency Medicine, Neurology and Neurosurgery
University of Cincinnati
Cincinnati, OH